Equip Artervac
Active substance
ATC code
Species
Horses and ponies from the age of 9 months.
Indications
For the active immunisation of horses and ponies against equine arteritis in order to reduce clinical signs and shedding of virus in nasal secretion after infection.
Onset of immunity: 3 weeks post primary vaccination
Duration of immunity: 6 months
Dose to be administered and administration route
Shake well before use.
1 ml dose per horse to be administered by intramuscular injection.
Primary course:
A single dose should be administered two times with an interval of 3-6 weeks from an age of nine months onwards.
Booster vaccinations are recommended every 6 months.
Adverse reactions
Minor transient (1 to 5 days) increase in body temperature (<40°C) and transient local reactions (for usually 2 to 3 days) may be very commonly observed in vaccinated horses. The swellings are usually less than 4 cm in diameter but in one horse a swelling of 20 cm lasting for 5 days was recorded. All swellings resolved.
Systemic reactions which includes depression and ocular and nasal discharge may be commonly observed. Urticaria and oedema of legs, abdomen or scrotum may be rarely observed.
In the event of an allergic or anaphylactic reaction, adrenaline should be administered intramuscularly.
The frequency of adverse reactions is defined using the following convention:
- very common (more than 1 in 10 animals treated displaying adverse reaction(s))
- common (more than 1 but less than 10 animals in 100 animals treated)
- uncommon (more than 1 but less than 10 animals in 1,000 animals treated)
- rare (more than 1 but less than 10 animals in 10,000 animals treated)
- very rare (less than 1 animal in 10,000 animals treated, including isolated reports).
